Date: 23 January 2024
Time: To be announced
Duration: 3 days
Location: Mercure Hotel MOA, Berlin, Germany
Cost: Register online for more information.
Organiser: Hanson Wade
The Largest Gathering for mRNA-Dedicated Professionals in Europe
The eagerly anticipated mRNA-Based Therapeutics Summit Europe returns to Berlin this January for the third year as Europe’s largest and most important gathering of mRNA experts.
Showcasing exclusive new data from the trailblazers and thought leaders in the field, join 200+ industry specialists including the likes of the MHRA, EMA, BioNTech, CureVac, Ziphius Vaccines, Moderna and more across 3 days to uncover groundbreaking discovery, pre-clinical and clinical insights in mRNA therapeutic and vaccine development to fast-track R&D and pipeline expansions.
Key Themes for 2024:
- Unlock European-specific regulatory expectations for mRNA therapeutics and vaccines to ensure compliance, identify potential risks and enable patient access to your drugs without delays;
- Overcome safety, PK/PD and translational hurdles to accelerate a surge of pre-clinical mRNA-based therapeutic candidates into robust clinical pipelines with emphasis on improving the efficiency and success of your drugs;
- Improve drug delivery vehicle design and molecule characterisation to overcome immunogenicity and thermostability hurdles;
- Maintain momentum in mRNA mergers and acquisitions, partnerships and investments in Europe and beyond to fuel the next generation of breakthroughs, reduce cost of goods and ensure R&D success beyond COVID-19.